Concepedia

Gilles Quéré

GQ

Statistics

Publications

22

Citations

1.5K

H-Index

15

Active since

2011

Affiliations

Centre Hospitalier Régional Universitaire de Brest(Current)

Inserm

Institut Gustave Roussy

Assistance Publique – Hôpitaux de Paris

Centre Hospitalier de Saint-Brieuc

Gilles Quéré is an author at Centre Hospitalier Régional Universitaire de Brest specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2011–2024

22

Publications

22

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

Alice Tison, Gilles Quéré, L. Misery et al. · Arthritis & Rheumatology · 2019 · 312 citations · Full text

, , +16

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont et al. · The Lancet Haematology · 2018 · 292 citations

, , +16

Good clinical practice recommendations for the use of PET/CT in oncology

Pierre‐Yves Salaün, Ronan Abgral, O. Malard et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 145 citations

, , +12

Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)

C. Decroisette, I. Monnet, H. Bérard et al. · Journal of Thoracic Oncology · 2011 · 134 citations

, , +17

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Guillaume Manson, Alexandre Maria, F. Poizeau et al. · Journal for ImmunoTherapy of Cancer · 2019 · 106 citations · Full text

, , +17

1–5 of 22